Unexpected Loss: Altimmune’s Chief Financial Officer Richard Eisenstadt Passes Away While Company Faces Financial Challenges. | CSIMarket News
CSI Market
Sign In | Register

Unexpected Loss: Altimmune’s Chief Financial Officer Richard Eisenstadt Passes Away While Company Faces Financial Challenges.

Published | Modified
CSIMarket Newsroom | CSIMarket.com
Illustrative image

Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt

Facts:- Altimmune, Inc. a clinical-stage biopharmaceutical company, has announced the unexpected passing of its Chief Financial Officer, Richard Eisenstadt.- Richard Eisenstadt’s untimely death occurred on Monday, June 24, 2024.- Altimmune Inc recorded a cumulative net loss of $93 million during the 12 months ending in the first quarter of 2024.- This negative financial performance resulted in a negative return on investment (ROI) of -52.85%.

Source for this article: Based on Altimmune inc ’s official statement
For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .
Tags:
#ManagementChanges, #ROI, #DirectorsandOfficers, #ManagementChanges, #ALT, #Altimmune inc, #Major Pharmaceutical Preparations
Share this article:
X LinkedIn Facebook Email
Link copied to clipboard.

Comments

Comments are available to active subscribers. Subscribe or Log in.
Get the full CSIMarket dataset: Subscribe API License